WALD Stock Forecast & Price Target

Waldencast is expected to see strong growth in its Obagi Skincare segment, driven by increasing demand in its DTC and international channels. However, its Milk Makeup segment may continue to face challenges, as seen in its YoY revenue contraction. The company's ongoing strategic review adds uncertainty, but potential outcomes such as selling a brand or the entire company could potentially benefit shareholders.

Waldencast is facing several challenges that are negatively impacting its financial performance and outlook. These include margin pressure from inventory-related adjustments and holiday promotions, slower growth and weaker demand at its Milk Makeup segment, and ongoing strategic review efforts that may not yield significant improvements. Additionally, there are industry-specific risks such as volatile commodity costs and changing consumer spending patterns that could further impact the company's performance. Overall, these factors contribute to a negative outlook for Waldencast's stock and suggest it may underperform in the near-term.